Deborah King

601 total citations
25 papers, 400 citations indexed

About

Deborah King is a scholar working on Virology, Immunology and Infectious Diseases. According to data from OpenAlex, Deborah King has authored 25 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Virology, 12 papers in Immunology and 6 papers in Infectious Diseases. Recurrent topics in Deborah King's work include HIV Research and Treatment (20 papers), Immune Cell Function and Interaction (10 papers) and T-cell and B-cell Immunology (6 papers). Deborah King is often cited by papers focused on HIV Research and Treatment (20 papers), Immune Cell Function and Interaction (10 papers) and T-cell and B-cell Immunology (6 papers). Deborah King collaborates with scholars based in United Kingdom, United States and Canada. Deborah King's co-authors include Robin J. Shattock, Paul F. McKay, Jamie F. S. Mann, Paul Rogers, Hannah M. Cheeseman, Keith R. Shockley, Karen L. Svenson, Gary A. Churchill, Daniel M. Gatti and Gabriel A. Knudsen and has published in prestigious journals such as PLoS ONE, Journal of Virology and Scientific Reports.

In The Last Decade

Deborah King

24 papers receiving 393 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deborah King United Kingdom 13 181 134 114 103 59 25 400
Ralf Geiben-Lynn United States 11 104 0.6× 164 1.2× 113 1.0× 68 0.7× 57 1.0× 16 344
Patricia Pérez Spain 13 69 0.4× 57 0.4× 103 0.9× 215 2.1× 86 1.5× 27 388
Joann Vennari United States 13 246 1.4× 154 1.1× 191 1.7× 130 1.3× 100 1.7× 14 526
Sunita Sharma United States 14 365 2.0× 311 2.3× 201 1.8× 134 1.3× 170 2.9× 43 659
Shahin Ranjbar United States 15 184 1.0× 194 1.4× 228 2.0× 255 2.5× 169 2.9× 24 621
Chester J. Joyner United States 16 34 0.2× 141 1.1× 93 0.8× 61 0.6× 31 0.5× 21 484
Susan K. Eszterhas United States 14 130 0.7× 148 1.1× 288 2.5× 121 1.2× 59 1.0× 26 590
Miranda S. Moore United States 12 105 0.6× 120 0.9× 700 6.1× 92 0.9× 146 2.5× 41 1.0k
Ildikó Tóth United States 9 356 2.0× 354 2.6× 104 0.9× 116 1.1× 57 1.0× 12 597
Yelina Alvarez United States 9 99 0.5× 275 2.1× 150 1.3× 86 0.8× 69 1.2× 16 491

Countries citing papers authored by Deborah King

Since Specialization
Citations

This map shows the geographic impact of Deborah King's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah King with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah King more than expected).

Fields of papers citing papers by Deborah King

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah King. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah King. The network helps show where Deborah King may publish in the future.

Co-authorship network of co-authors of Deborah King

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah King. A scholar is included among the top collaborators of Deborah King based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah King. Deborah King is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Duijn, Janine van, Daniel J Stieh, Natalia Fernández, et al.. (2023). Mosaic HIV-1 vaccination induces anti-viral CD8 + T cell functionality in the phase 1/2a clinical trial APPROACH. Journal of Virology. 97(10). e0112623–e0112623. 2 indexed citations
2.
Fernández, Natalia, Peter Hayes, Julia Makinde, et al.. (2022). Assessment of a diverse panel of transmitted/founder HIV-1 infectious molecular clones in a luciferase based CD8 T-cell mediated viral inhibition assay. Frontiers in Immunology. 13. 1029029–1029029. 1 indexed citations
3.
Manak, Mark, Deborah King, Bernd Abel, et al.. (2022). Development of a sensitive, quantitative assay with broad subtype specificity for detection of total HIV-1 nucleic acids in plasma and PBMC. Scientific Reports. 12(1). 1550–1550. 11 indexed citations
4.
5.
Makinde, Julia, Eunice Nduati, Anna Freni Sterrantino, et al.. (2021). A Novel Sample Selection Approach to Aid the Identification of Factors That Correlate With the Control of HIV-1 Infection. Frontiers in Immunology. 12. 634832–634832. 4 indexed citations
6.
Ung, Seng Kuong Anakin, Peter Hayes, S. Lucas Black, et al.. (2021). HIV-1 infection and the lack of viral control are associated with greater expression of interleukin-21 receptor on CD8+ T cells. AIDS. 35(8). 1167–1177. 3 indexed citations
7.
Yue, Ling, Ecco Staller, Darío Dilernia, et al.. (2020). Infection with multiple HIV-1 founder variants is associated with lower viral replicative capacity, faster CD4+ T cell decline and increased immune activation during acute infection. PLoS Pathogens. 16(9). e1008853–e1008853. 10 indexed citations
8.
Mann, Jamie F. S., Katja Klein, Paul F. McKay, et al.. (2020). A targeted reactivation of latent HIV-1 using an activator vector in patient samples from acute infection. EBioMedicine. 59. 102853–102853. 10 indexed citations
9.
Klein, Katja, Paul F. McKay, Deborah King, et al.. (2018). A heterogeneous human immunodeficiency virus-like particle (VLP) formulation produced by a novel vector system. npj Vaccines. 3(1). 2–2. 17 indexed citations
10.
Arakelyan, Anush, Wendy Fitzgerald, Deborah King, et al.. (2017). Flow virometry analysis of envelope glycoprotein conformations on individual HIV virions. Scientific Reports. 7(1). 948–948. 23 indexed citations
11.
McKay, Paul F., Deborah King, Jamie F. S. Mann, et al.. (2016). TLR4 and TLR7/8 Adjuvant Combinations Generate Different Vaccine Antigen-Specific Immune Outcomes in Minipigs when Administered via the ID or IN Routes. PLoS ONE. 11(2). e0148984–e0148984. 26 indexed citations
12.
Cheeseman, Hannah M., Ann M. Carias, Abbey Evans, et al.. (2016). Expression Profile of Human Fc Receptors in Mucosal Tissue: Implications for Antibody-Dependent Cellular Effector Functions Targeting HIV-1 Transmission. PLoS ONE. 11(5). e0154656–e0154656. 18 indexed citations
13.
King, Deborah, et al.. (2015). Plasmid DNA Vaccine Co-Immunisation Modulates Cellular and Humoral Immune Responses Induced by Intranasal Inoculation in Mice. PLoS ONE. 10(11). e0141557–e0141557. 5 indexed citations
14.
Veazey, Ronald S., Asna A. Siddiqui, Katja Klein, et al.. (2015). Evaluation of mucosal adjuvants and immunization routes for the induction of systemic and mucosal humoral immune responses in macaques. Human Vaccines & Immunotherapeutics. 11(12). 2913–2922. 15 indexed citations
15.
Stieh, Daniel J, Deborah King, Katja Klein, et al.. (2015). Discrete partitioning of HIV-1 Env forms revealed by viral capture. Retrovirology. 12(1). 81–81. 13 indexed citations
16.
Stieh, Daniel J, Deborah King, Katja Klein, et al.. (2014). Aggregate complexes of HIV-1 induced by multimeric antibodies. Retrovirology. 11(1). 78–78. 24 indexed citations
17.
French, John E., Daniel M. Gatti, Daniel L. Morgan, et al.. (2014). Diversity Outbred Mice Identify Population-Based Exposure Thresholds and Genetic Factors that Influence Benzene-Induced Genotoxicity. Environmental Health Perspectives. 123(3). 237–245. 92 indexed citations
18.
Stieh, Daniel J, Joshua L. Phillips, Paul Rogers, et al.. (2013). Dynamic electrophoretic fingerprinting of the HIV-1 envelope glycoprotein. Retrovirology. 10(1). 33–33. 10 indexed citations
19.
Trillo‐Pazos, Gusta, et al.. (2004). Infection of stationary human brain aggregates with HIV‐1 SF162 and IIIB results in transient neuronal damage and neurotoxicity. Neuropathology and Applied Neurobiology. 30(2). 136–147. 10 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ralf Geiben-Lynn Breakdown of academic impact, for papers by Patricia Pérez Breakdown of academic impact, for papers by Joann Vennari Breakdown of academic impact, for papers by Sunita Sharma Breakdown of academic impact, for papers by Shahin Ranjbar Breakdown of academic impact, for papers by Chester J. Joyner Breakdown of academic impact, for papers by Susan K. Eszterhas Breakdown of academic impact, for papers by Miranda S. Moore Breakdown of academic impact, for papers by Ildikó Tóth Breakdown of academic impact, for papers by Yelina Alvarez
Rankless by CCL
2026